These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

564 related articles for article (PubMed ID: 35409220)

  • 21. Gut Microbiota and Autism: Key Concepts and Findings.
    Ding HT; Taur Y; Walkup JT
    J Autism Dev Disord; 2017 Feb; 47(2):480-489. PubMed ID: 27882443
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relationship between absolute and relative ratios of glutamate, glutamine and GABA and severity of autism spectrum disorder.
    Al-Otaish H; Al-Ayadhi L; Bjørklund G; Chirumbolo S; Urbina MA; El-Ansary A
    Metab Brain Dis; 2018 Jun; 33(3):843-854. PubMed ID: 29397522
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The microbiota-gut-brain axis and its potential therapeutic role in autism spectrum disorder.
    Li Q; Zhou JM
    Neuroscience; 2016 Jun; 324():131-9. PubMed ID: 26964681
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Palmitoylethanolamide and Its Biobehavioral Correlates in Autism Spectrum Disorder: A Systematic Review of Human and Animal Evidence.
    Colizzi M; Bortoletto R; Costa R; Zoccante L
    Nutrients; 2021 Apr; 13(4):. PubMed ID: 33919499
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The neurobiological bases of autism spectrum disorders: the R451C-neuroligin 3 mutation hampers the expression of long-term synaptic depression in the dorsal striatum.
    Martella G; Meringolo M; Trobiani L; De Jaco A; Pisani A; Bonsi P
    Eur J Neurosci; 2018 Mar; 47(6):701-708. PubMed ID: 28921757
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glutamatergic Dysfunction and Synaptic Ultrastructural Alterations in Schizophrenia and Autism Spectrum Disorder: Evidence from Human and Rodent Studies.
    Eltokhi A; Santuy A; Merchan-Perez A; Sprengel R
    Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33374598
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Brain-Gut-Microbiome System: Pathways and Implications for Autism Spectrum Disorder.
    Chernikova MA; Flores GD; Kilroy E; Labus JS; Mayer EA; Aziz-Zadeh L
    Nutrients; 2021 Dec; 13(12):. PubMed ID: 34960049
    [TBL] [Abstract][Full Text] [Related]  

  • 28. GABAergic/glutamatergic imbalance relative to excessive neuroinflammation in autism spectrum disorders.
    El-Ansary A; Al-Ayadhi L
    J Neuroinflammation; 2014 Nov; 11():189. PubMed ID: 25407263
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reduced subcortical glutamate/glutamine in adults with autism spectrum disorders: a [¹H]MRS study.
    Horder J; Lavender T; Mendez MA; O'Gorman R; Daly E; Craig MC; Lythgoe DJ; Barker GJ; Murphy DG
    Transl Psychiatry; 2013 Jul; 3(7):e279. PubMed ID: 23838890
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Glutamate mediated signaling in the pathophysiology of autism spectrum disorders.
    Choudhury PR; Lahiri S; Rajamma U
    Pharmacol Biochem Behav; 2012 Feb; 100(4):841-9. PubMed ID: 21756930
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New and Preliminary Evidence on Altered Oral and Gut Microbiota in Individuals with Autism Spectrum Disorder (ASD): Implications for ASD Diagnosis and Subtyping Based on Microbial Biomarkers.
    Kong X; Liu J; Cetinbas M; Sadreyev R; Koh M; Huang H; Adeseye A; He P; Zhu J; Russell H; Hobbie C; Liu K; Onderdonk AB
    Nutrients; 2019 Sep; 11(9):. PubMed ID: 31489949
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reduced Glutamate Release in Adult BTBR Mouse Model of Autism Spectrum Disorder.
    Wei H; Ma Y; Ding C; Jin G; Liu J; Chang Q; Hu F; Yu L
    Neurochem Res; 2016 Nov; 41(11):3129-3137. PubMed ID: 27538958
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glutamatergic candidate genes in autism spectrum disorder: an overview.
    Chiocchetti AG; Bour HS; Freitag CM
    J Neural Transm (Vienna); 2014 Sep; 121(9):1081-106. PubMed ID: 24493018
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of gut microbiota profiles and microbe-disease associations in children with autism spectrum disorders in China.
    Zhang M; Ma W; Zhang J; He Y; Wang J
    Sci Rep; 2018 Sep; 8(1):13981. PubMed ID: 30228282
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Autism genetics - an overview.
    Yin J; Schaaf CP
    Prenat Diagn; 2017 Jan; 37(1):14-30. PubMed ID: 27743394
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The neurochemical basis for the treatment of autism spectrum disorders and Fragile X Syndrome.
    Hampson DR; Adusei DC; Pacey LK
    Biochem Pharmacol; 2011 May; 81(9):1078-86. PubMed ID: 21333634
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of the Gut Microbiome in Autism Spectrum Disorders.
    Pulikkan J; Mazumder A; Grace T
    Adv Exp Med Biol; 2019; 1118():253-269. PubMed ID: 30747427
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of the Gut Microbiota in the Pathophysiology of Autism Spectrum Disorder: Clinical and Preclinical Evidence.
    Roussin L; Prince N; Perez-Pardo P; Kraneveld AD; Rabot S; Naudon L
    Microorganisms; 2020 Sep; 8(9):. PubMed ID: 32906656
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Perturbance of Microbiome and Gut-Brain Axis in Autism Spectrum Disorders.
    Fowlie G; Cohen N; Ming X
    Int J Mol Sci; 2018 Aug; 19(8):. PubMed ID: 30071612
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [A review on the role of γ-aminobutyric acid signaling pathway in autism spectrum disorder].
    Wang B; Li HH; Yue XJ; Jia FY; DU L
    Zhongguo Dang Dai Er Ke Za Zhi; 2018 Nov; 20(11):974-978. PubMed ID: 30477634
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.